CF 101, B / CF Z 200, B

Hazard statements (CLP)

H315, H317, H319, H332, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled.

2.2 Label elements

Labelling

Hazard pictograms

GHS07 GHS08

Signal word

Warning

Contains

4,4'-diphenylmethanediisocyanate, isomeres and homologues

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P260 - Do not breathe vapours. P280 - Wear protective gloves, protective clothing, eye protection. P284 - In case of inadequate ventilation wear respiratory protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.

Additional information

As from 24 August 2023 adequate training is required before industrial or professional use.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component 4,4'-diphenylmethanediisocyanate, isomeres and homologues (9016-87-9) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component 4,4'-diphenylmethanediisocyanate, isomeres and homologues (9016-87-9) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605